UBS Group begins coverage of Karuna Therapeutics (NASDAQ:KRTX).
A report on Friday indicated that investment analysts at UBS Group have started following Karuna Therapeutics (NASDAQ: KRTX). Mhe company’s stock that it is selling …
A report on Friday indicated that investment analysts at UBS Group have started following Karuna Therapeutics (NASDAQ: KRTX). Mhe company’s stock that it is selling …
On January 9, an insider named Stephen K. Brannan was responsible for selling 5,000 shares of Karuna Therapeutics, Inc. (NASDAQ: KRTX) stock. With a price …